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PXPEDITED REVIEW
yocardial Contrast Echocardiography Versus
hrombolysis in Myocardial Infarction Score in
atients Presenting to the Emergency Department
ith Chest Pain and a Nondiagnostic Electrocardiogram
him Leng Tong, MD,* Sanjiv Kaul, MD, FACC,* Xin-Qun Wang, MS,† Diana Rinkevich, MD, FACC,*
aul Kalvaitis, MD,* Todd Belcik, RDCS,* Wolfgang Lepper, MD,* William A. Foster, MD,*
evin Wei, MD, FACC*
harlottesville, Virginia
OBJECTIVES We hypothesized that regional function (RF) and myocardial perfusion (MP) are superior to
the Thrombolysis In Myocardial Infarction (TIMI) score for diagnosis and prognostication
in patients presenting to the emergency department (ED) with chest pain (CP) and a
nondiagnostic electrocardiogram.
BACKGROUND Rapid diagnosis and prognostication is difficult in patients presenting to the ED with
suspected cardiac CP.
METHODS Contrast echocardiography was performed to assess RF and MP on 957 patients presenting
to the ED with suspected cardiac CP and a nondiagnostic electrocardiogram. A modified
TIMI (mTIMI) score was calculated from six immediately available variables. A full TIMI
score also was derived after troponin levels were able to be accessed adequately. Follow-up was
performed for early (within 24 h), intermediate (30 day), and late primary (death and
myocardial infarction) or secondary (unstable angina and revascularization) events.
RESULTS The mTIMI score was unable to discriminate between intermediate- compared to high-risk
patients at any follow-up time point, whereas only 2 of 523 patients with normal RF had an
early primary event. Regional function provided incremental prognostic value over mTIMI
scores for predicting intermediate and late events. In patients with abnormal RF, MP further
classified patients into intermediate- and high-risk groups. The full TIMI score could not
improve upon these results at any follow-up time point.
CONCLUSIONS Contrast echocardiography can rapidly and accurately provide short-, intermediate-, and
long-term prognostic information in patients presenting to the ED with suspected cardiac CP
even before serum cardiac markers are known. Integrating contrast echocardiography into the
ED evaluation of CP may improve the risk stratification of such patients. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.03.076Cardiol 2005;46:920–7) © 2005 by the American College of Cardiology Foundation
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phest pain (CP) is a common complaint in patients seeking
are from an emergency department (ED). The electrocar-
See page 928
iogram (ECG) is effective in helping to diagnose 30% to
0% of patients with acute myocardial infarction (AMI)
1–3), and early determinations of serum cardiac enzymes
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Division of Biostatistics and Epidemiology, Department of Health Evaluation
ciences, University of Virginia School of Medicine, Charlottesville, Virginia. Drs.
ong and Kalvaitis were recipients of Research Fellowship Awards from the National
edical Research Council of Singapore and POINT Biomedical Corporation (San
arlos, California), respectively. Dr. Wei was the recipient of a Mentored Clinical
cientist Development Award (K08-HL03909) from the National Institutes of
ealth. Current address of Dr. Tong: Changi General Hospital, Singapore. Pre-
ented in part at the Samuel Levine Young Investigator Award Competition at the
7th Annual Scientific Session of the American Heart Association, New Orleans,
ouisiana. Drs. Kaul and Wei are currently located at the Cardiovascular Division,
HSU, Portland, Oregon.n
Manuscript received May 6, 2004; revised manuscript received March 27, 2005,
ccepted March 29, 2005.requently are negative (4,5). The unreliability of these
arameters results, on one hand, in the inadvertent dis-
harge of approximately 5% of patients with ongoing AMI
nd, on the other hand, unnecessary hospital admissions (6).
Apart from the identification of ischemia, the accurate risk
tratification of these patients also is important. Those patients
ho are at intermediate or high risk for an adverse outcome
ay require admission to a coronary care or telemetry unit,
reatment with potent antiplatelet agents (7–9), or early referral
or cardiac catheterization (10). The presence of elevated levels
f troponin identifies those patients at increased risk and is a
omponent of the Thrombolysis In Myocardial Infarction
TIMI) risk score (11). It may, however, not be elevated or
mmediately available at the time of patient presentation. Thus,
omplete risk stratification and initiation of therapy may be
nnecessarily delayed. We hypothesized that an assessment of
eft ventricular (LV) regional function (RF) and myocardial
erfusion (MP) would be superior to the TIMI score in
atients presenting to an ED with suspected cardiac CP and
o ST-segment elevation on the ECG.
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atient population. This study was approved by the Hu-
an Investigation Committee at the University of Virginia.
atients 30 years of age who presented to the ED with a
omplaint of CP of 30 min in duration that was not easily
ttributable to an obvious noncardiac cause and who did not
xhibit ST-segment elevation on the ECG were enrolled in
he study. All patients had their contrast echocardiography
CE) study completed within 12 h of the onset of their
ymptoms. All patients provided written informed consent.
etermination of TIMI risk score. The TIMI risk score
as calculated as previously defined (11). A score of 1 was
ssigned to each of the following seven variables when
resent: age 65 years, more than three coronary disease
isk factors, known coronary luminal diameter narrowing of
50%, ST-segment deviation on ECG, two or more angina
vents in the previous 24 h, use of aspirin in the previous
even days, and elevated levels of troponin. The TIMI risk
core was calculated as the sum of all scores.
We also wanted to evaluate the prognostic utility of a
core derived from variables that are available immediately
t the time of ED presentation. Because of inherent delays
n receiving laboratory results and because troponin eleva-
ion may be delayed for many hours after the initial
resentation, a modified TIMI risk score (mTIMI) that
xcluded this variable was derived (maximum score of 6).
ontrast echocardiography. An infusion of 3 ml of Op-
ison (GE Healthcare, Princeton, New Jersey) diluted in 60
l of saline was administered intravenously at a rate of 3
able 1. Early Events in Different mTIMI and TIMI Groups
mTIMI Risk Group
Event,
n (%)
Low
(n  586)
Intermediate
(n  326)
MI 24 (4.1) 35 (11.0)
ll-cause mortality 1 (0.2) 1 (0.3)
otal primary events 25 (4.3) 36 (11.3)
nstable angina 11 (1.9) 28 (8.6)
CI 1 (0.2) 7 (2.1)
ABG 1 (0.2) 2 (0.6)
otal secondary events 18 (3.1) 44 (13.3)
Abbreviations and Acronyms
AMI  acute myocardial infarction
CE  contrast echocardiography
CP  chest pain
ECG  electrocardiogram
ED  emergency department
LV  left ventricular
MP  myocardial perfusion
mTIMI  modified Thrombolysis In Myocardial
Infarction
RF  regional function
TIMI  Thrombolysis In Myocardial InfarctionMI  acute myocardial infarction; CABG  coronary artery bypass graft surgery; mTIM
ntervention; TIMI  Thrombolysis In Myocardial Infarction.l · min1 using a syringe pump (model AS40A, Baxter,
eerfield, Illinois). Imaging was performed using a Sonos
500 system (Phillips Ultrasound, Andover, Massachu-
etts). Regional function data were acquired using low
echanical index harmonic imaging and contrast for LV
order delineation.
For MP, intermittent high mechanical index ultrahar-
onic imaging was performed using transmit/receive fre-
uencies of 1.3/3.6 MHz, respectively, with ultrasound
ransmission gated to the ECG at end-systole. Images were
cquired digitally at pulsing intervals of 1, 2, 3, 4, and 5
ycles. Compression was set at 75%, and all gain settings
ere optimized at the beginning of the study and then held
onstant. If a signal from myocardial regions was discern-
ble despite optimization of ultraharmonic image settings,
ntermittent harmonic power Doppler was performed to
chieve better tissue signal suppression. The transmit focus
nitially was set at the level of the mitral valve but was
oved to the apex when an apical defect was observed to
xclude the apical destruction artifact (Video A; see the
nline version of this article for all videos). Off-axis images
ere acquired as needed. Regional function and MP data
ere acquired digitally onto magneto-optical disks.
Regional function and MP studies were interpreted
eparately by experienced observers who were blinded to all
ata: both were scored visually using a 14-segment model as
ormal, abnormal, or not interpretable (12). The segments
ere then grouped into anteroapical, lateral, or inferopos-
erior territories. Studies were classified as normal if RF or
P in the majority of segments within each perfusion
erritory were normal. Studies were called abnormal if RF or
P was abnormal in one or more territories, even if all
erritories were not visualized. If a study could not be
lassified as previously mentioned, it was deemed not
ssessable.
tudy protocol. All patients had a complete history and
hysical examination as well as a 12-lead ECG. Blood was
rawn for troponin I at the time of ED presentation and
epeated twice at 6-h intervals. Troponin I levels were
easured using a direct chemiluminometric immunoassay
Bayer, Tarrytown, New York). Contrast echocardiography
as performed as soon as possible after the patient’s
TIMI Risk Group
High
n  45)
Low
(n  560)
Intermediate
(n  305)
High
(n  92)
4 (8.9) 11 (2.0) 29 (9.5) 23 (26.0)
0 (0) 1 (0.2) 0 (0) 1 (1.1)
4 (8.9) 12 (2.2) 29 (9.5) 24 (27.1)
9 (20.0) 8 (1.4) 25 (8.2) 15 (16.0)
1 (2.2) 1 (0.2) 6 (2.0) 2 (2.2)
0 (0) 1 (0.2) 1 (0.3) 1 (1.1)
1 (24.4) 15 (2.7) 37 (14.8) 21 (22.6)(
1I  modified Thrombolysis In Myocardial Infarction; PCI  percutaneous coronary
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Contrast Echocardiography for Chest Pain September 6, 2005:920–7resentation to the ED. Information regarding RF or MP
as not shared with the ED physician, and the decision to
dmit or discharge was based solely on routine clinical,
aboratory, and ECG criteria.
Follow-up was obtained by questionnaire or telephone
nterview with the patient, patient’s family, physician, or a
ombination. All reported events were confirmed by review
f medical charts or other documents (for example, death
ertificates). Primary end points included all-cause mortality
nd AMI, which was defined by an abnormally elevated
roponin I level (0.6 ng · ml1). Secondary events in-
luded revascularization (either coronary artery bypass sur-
ery or percutaneous coronary intervention) and unstable
ngina, defined as ischemic CP of 30 min duration
ssociated with dynamic ECG changes and/or mild tropo-
in elevation (0.08 to 0.6 ng · ml1) and requiring hospi-
alization and/or revascularization. Secondary events occur-
ing before a primary event were ignored. If a patient had
ore than one event, only the first was considered for
nalysis. Cumulative patient outcomes were determined at
hree time points: early (within the first 24 h), intermediate
up to 30 days), and late (30 days).
tatistical methods. The explanatory variables were the
ame for all types of models. To test whether RF or RF plus
P had the ability to discriminate between subjects with
ifferent TIMI risk scores, logistic regression models
13,14) were applied for cumulative events that had accrued
t early and intermediate time points, and Cox proportional
azards regression models (14,15) were used for cumulative
vents at the late time point. Adjusted survival probabilities
or late events also were estimated based on the Cox
roportional hazards survival model (16). A Wald chi-
quare test was used to assess the significance of each
redictor and an odds ratio (OR) or a hazard ratio was used
o quantify its effect. A log likelihood ratio test was applied
o determine whether RF and/or MP provided additional
nformation to the TIMI scores in predicting events. The
rea under the receiver-operating characteristic curve (or
-index) was used to quantify the discriminatory power of
F or combined RF and MP (14). C-indices of0.69, 0.70
o 0.79, and 0.79 indicated poor, good, and excellent
Table 2. Early Events in Different CE Groups
Event,
n (%)
Normal RF
Normal MP
(n  485)
N
Ab
AMI 1 (0.2)
All-cause mortality 1 (0.2)
Total primary events 2 (0.4)
Unstable angina 8 (1.6)
PCI 6 (1.2)
CABG 1 (0.2)
Total secondary events 15 (3.0)
CE  contrast echocardiography; MP  myocardial perfusiiscrimination, respectively.
g
ESULTS
atient characteristics. Between October 2000 and Janu-
ry 2003, 1,236 patients were recruited. Of these, 86 (7%)
ad no follow-up, and 151 had RF or MP studies of
nadequate quality (12%). Another 42 (3%) developed
T-segment elevation on the ECG after being admitted to
he ED and were excluded from analysis. Therefore, a total
f 957 patients are presented in this report, of whom 153
16%) had CE performed during ongoing CP. No signifi-
ant differences were found in demographics between pa-
ients who were excluded and the study group.
A little more than one half (52%) of the 957 patients were
en; the median age was 60 years (range, 32 to 92 years),
7% were smokers, 28% had diabetes, 53% had hypercho-
esterolemia, 47% had a family history of coronary artery
isease, and 66% had essential hypertension.
On the basis of their mTIMI or TIMI scores, patients were
ategorized as either low (score2), intermediate (score of 3 or
), or high (score 5) risk. In 485 of the 957 patients (51%),
oth RF and MP were normal (Video A); in 164 (17%), RF
as abnormal but MP was normal (Video B); in 270 (28%),
igure 1. Ability of tests performed in a hierarchical order for predicting
arly events. See text for details. MP  myocardial perfusion; mTIMI 
odified Thrombolysis In Myocardial Infarction; RF  regional function;
IMI  Thrombolysis In Myocardial Infarction. Open bars  mTIMI;
al RF
al MP
38)
Abnormal RF
Normal MP
(n  164)
Abnormal RF
Abnormal MP
(n  270)
.6) 16 (9.8) 45 (16.0)
) 0 (0) 1 (0.37)
.6) 16 (9.8) 46 (16.4)
) 9 (5.5) 31 (11.0)
.6) 1 (0.6) 2 (0.7)
) 0 (0) 2 (0.7)
.6) 13 (7.9) 44 (16.2)
 regional function; other abbreviations as in Table 1.orm
norm
(n 
1 (2
0 (0
1 (2
0 (0
1 (2
0 (0
1 (2ray barsmTIMI RF; black barsmTIMI RFMP; ruled bars
TIMI.
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September 6, 2005:920–7 Contrast Echocardiography for Chest Painoth RF and MP were abnormal (Video C); and in 38 (4%),
F was normal but MP was abnormal.
arly events. The incidence of early events based on the
TIMI score is shown in Table 1. Acute myocardial
nfarction was the most common event in all groups.
lthough patients with a low mTIMI score had the lowest
ncidence of primary events, 24 (4.1%) of these still had an
MI. Patients with an intermediate score had a similar
MI event rate as those with a high-risk score (11% vs.
.9%, p  0.71). Thus, the mTIMI score was unable to
iscriminate between these groups.
Table 2 depicts early events in patients with different RF
nd MP findings. The presence of normal RF identified a
opulation at low risk of a primary event (n  2, 0.4%).
urthermore, in patients with abnormal RF, those with
ormal MP had a significantly lower event rate than those
ith abnormal MP (9.8% vs. 16%; p  0.05). A significant
nteraction was observed between the mTIMI score and RF.
n patients with a low mTIMI score (2), those with
ormal RF were significantly less likely to have an event
ompared with those with abnormal RF (OR 0.11; 95%
onfidence interval 0.05 to 0.25; p  0.001). Likewise,
atients with an intermediate mTIMI score (3 or 4) who
ad normal RF were also significantly less likely to have an
vent (OR 0.14, 95% confidence interval 0.07 to 0.30; p 
.001). In patients with the highest mTIMI scores (5),
owever, RF did not provide additional information. After
erum cardiac markers were included into the final TIMI
core, approximately 5% of patients in the low- and
ntermediate-mTIMI risk groups were reassigned to
igher-risk groups. Similar to previous reports (11), the
able 3. Intermediate Events in Different mTIMI and TIMI Gr
Event,
n (%)
mTIMI Risk Group
Low
(n  586)
Intermediate
(n  326)
MI 25 (4.3) 37 (11.3)
ll-cause mortality 1 (0.2) 2 (0.6)
otal primary events 26 (4.4) 41 (12.6)
nstable angina 12 (2.0) 31 (9.5)
CI 3 (0.5) 10 (3.1)
ABG 2 (0.3) 5 (1.5)
otal secondary events 17 (2.9) 46 (14.1)
bbreviations as in Table 1.
Table 4. Intermediate Events in Different CE
Event,
n (%)
Normal RF
Normal MP
(n  485)
N
Ab
AMI 1 (0.2)
All-cause mortality 2 (0.4)
Total primary events 3 (0.6)
Unstable angina 8 (1.6)
PCI 8 (1.6)
CABG 4 (0.8)
Total secondary events 20 (4.0)Abbreviations as in Tables 1 and 2.omplete TIMI score adequately risk stratified patients into
ow, intermediate, and high risk for early events. However,
ecause of a primary event rate of2% even in patients with
low score, use of the TIMI score alone would not allow
ischarge from the ED.
Figure 1 illustrates the predictive value of tests performed
n a hierarchical order. By adding RF to the mTIMI score,
he C-index increased from 0.68 to 0.79, and the model
rovided 127% additional information compared with the
TIMI score alone (p  0.001). The addition of MP
rovided 148% additional information compared with
TIMI score alone (p  0.001). A complete TIMI score
id not provide any more information compared with that
lready available from the combination of the mTIMI score
nd the CE information (C-index of 0.77 vs. 0.80).
ntermediate events. The incidence of events at 30-day
ollow-up in low-, intermediate-, and high-risk patients
ased on the mTIMI and TIMI scores are shown in Table
, and those in the different CE groups are shown in Table
. Similar to the data for early events, RF provided 85%
dditional prognostic information (p  0.001), whereas RF
lus MP provided 99% incremental predictive benefit (p 
.001) compared with the mTIMI score alone (Fig. 2).
ate events. Patients were followed for up to two years
median, 8.2 months). The incidence of late events in various
TIMI and TIMI groups is shown in Table 5, whereas Table
depicts the results derived from different RF and MP
ubgroups. The predictive ability of tests performed in a
ierarchical order based on the C-index derived from individ-
al Cox regression models are shown in Figure 3. The mTIMI
core had the weakest predictive ability and was superseded by
TIMI Risk Group
High
n  45)
Low
(n  560)
Intermediate
(n  305)
High
(n  92)
8 (17.8) 12 (2.1) 30 (9.8) 28 (30.4)
1 (2.2) 1 (0.2) 2 (0.6) 3 (3.3)
9 (20.0) 13 (2.3) 32 (10.5) 31 (33.7)
1 (24.4) 8 (1.4) 28 (9.2) 18 (19.6)
1 (2.2) 3 (0.5) 9 (3.0) 2 (2.2)
1 (2.2) 2 (0.4) 4 (1.3) 2 (2.2)
3 (28.9) 13 (2.3) 41 (13.4) 22 (23.9)
ps
al RF
al MP
38)
Abnormal RF
Normal MP
(n  164)
Abnormal RF
Abnormal MP
(n  270)
.6) 18 (11.0) 50 (18.5)
) 1 (0.6) 3 (1.1)
.6) 19 (11.6) 53 (19.6)
) 12 (7.3) 34 (12.6)
.6) 2 (1.2) 3 (1.1)
) 0 (0) 4 (1.5)
.6) 14 (8.5) 41 (15.2)oups
(
1
1Grou
orm
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Contrast Echocardiography for Chest Pain September 6, 2005:920–7he addition of RF. Myocardial perfusion provided further
ncremental value to RF. The complete TIMI score provided
reater prognostic information compared with that already
vailable from the CE study. Unlike the setting of early events,
here troponin markedly improved the ability of the mTIMI
core for predicting events (0.77 vs. 0.68), it had only a
arginal effect on the mTIMI score for predicting late events
0.74 vs. 0.69).
Figures 4 and 5 show the incremental benefit of RF and
P over clinical variables alone in patients with low (2)
nd intermediate (3 to 4) mTIMI scores, respectively.
hose with both abnormal RF and MP had a significantly
orse two-year event-free survival compared with those
ith abnormal RF but preserved MP (p 0.01). In patients
ith a high (5) mTIMI score, however, CE did not
rovide any further risk stratification.
ISCUSSION
atients presenting to the ED with suspected cardiac CP
ut no ST-segment elevation on the ECG pose a challenge.
hose patients at high risk for developing events and thus
equiring immediate hospitalization need to be separated
igure 2. Ability of tests performed in a hierarchical order for predicting
ntermediate events. See text for details. Abbreviations as in Figure 1. Open
ars mTIMI; gray bars mTIMI RF; black bars mTIMI RF
P; ruled bars  TIMI.
able 5. Late Events in Different mTIMI and TIMI Groups
mTIMI Risk Group
Event,
n (%)
Low
(n  586)
Intermediate
(n  326)
MI 37 (6.3) 53 (16.3)
ll-cause mortality 12 (2.2) 18 (5.5)
otal primary events 49 (8.4) 71 (21.8)
nstable angina 17 (2.9) 39 (12.0)
CI 6 (1.0) 13 (4.0)
ABG 4 (0.7) 7 (2.1)
otal secondary events 27 (4.6) 59 (18.1)bbreviations as in Table 1.rom those who are at low risk and can be safely discharged.
he new finding in this study is that before obtaining
roponin levels, the use of a composite score calculated from
mmediately assessable clinical variables (mTIMI) does not
dequately risk stratify all patients with CP and that the
ssessment of RF and MP on CE, combined with these
linical variables, provides superior diagnostic and prognos-
ic information when compared with even the complete
IMI score.
In the U.S., more than 6 million people present annually
o EDs with symptoms that are suggestive of myocardial
schemia (13). The principal tools that are used for diagnosis
nd prognostication include history and physical examina-
ion, ECG, cardiac serum markers, and stress testing. The
CG is nondiagnostic in a significant number of patients
ith CP (2,3), and the kinetics of biochemical cardiac
arker release make them insensitive for myocardial injury
t the time of the patient’s presentation to the ED (4,5).
onsequently, many patients with a nondiagnostic ECG
re admitted to the hospital unnecessarily to “rule out” an
cute coronary syndrome. Most of these patients do not
ave acute myocardial ischemia or even coronary artery
isease. Thus, the current “rule out” strategy wastes billions
f dollars annually.
The patients admitted for “rule out” are very heteroge-
eous and represent a wide risk range for developing a
erious cardiac event. However, the assessment of risk is
ssential for triage to an adequate location for care (regular
ard vs. step-down unit vs. coronary care unit) and to
etermine those who could benefit the most from aggressive
herapy. Although single variables (such as ECG abnormal-
ties or elevated serum cardiac markers) (17–21) have
rognostic value, the composite TIMI score has been shown
o effectively categorize risk of cardiovascular events and has
een proposed for use in clinical decision making (11).
arly events. In this study, we found that patients with a
ow mTIMI score could not be discharged from the ED
ecause of a substantial event rate within 24 h. In compar-
son, RF on CE has an excellent negative predictive value—
nly 0.4% of patients had an early primary event. In those
ith abnormal RF, an assessment of MP provided addi-
ional information. Contrast echocardiography also can
rovide additional information in patients with either a low
TIMI Risk Group
High
n  45)
Low
(n  560)
Intermediate
(n  305)
High
(n  92)
2 (26.7) 23 (4.1) 45 (14.8) 34 (37.0)
4 (8.8) 12 (2.1) 14 (4.6) 8 (8.6)
6 (35.6) 35 (6.3) 59 (19.3) 42 (45.7)
2 (26.7) 13 (2.3) 36 (11.8) 19 (20.7)
1 (2.2) 6 (1.1) 12 (3.9) 2 (2.2)
1 (2.2) 4 (0.7) 6 (2.0) 2 (2.2)
4 (31.1) 23 (4.1) 54 (17.7) 23 (25.0)(
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September 6, 2005:920–7 Contrast Echocardiography for Chest Painr intermediate mTIMI score. Those patients with normal
F had a significantly lower risk of an early event compared
ith those with abnormal RF. The complete TIMI score
hat also includes troponin was not found to provide
ncremental information compared with the combination of
he mTIMI score and CE.
ntermediate and late events. Previous studies have shown
hat clinical variables, such as the history, physical exami-
ation, and ECG, are suboptimal for identifying patients at
igh risk for late cardiovascular events that develop 24 h
fter presentation (22). Because the incidence of late events
ay be as high as that of early ones (22), early identification
f those at risk for future events is imperative for planning
urther follow-up or diagnostic studies. Our results indicate
hat CE provides superior information to the mTIMI score
n these patients and that combining clinical variables with
E provides better risk stratification than clinical variables
lus troponin (the complete TIMI score) for predicting late
vents. A previous study also has reported nonsuperiority of
roponin over RF in predicting events (23).
tudy limitations. Although the performance of CE may
e feasible during the day in most medical centers, the
ogistics of nighttime performance and interpretation of
mages is not clear. It is imperative for studies to be of high
uality and all myocardial segments to be well delineated.
ven with state-of-the-art systems and tissue harmonic
maging, endocardial borders are visualized inadequately in
sizeable minority of patients that is reduced markedly
hen CE is performed.
The evaluation of RF abnormalities on echocardiography
s one of the most subjective and difficult skills to master. In
his context, CE has been shown to improve visualization of
ndocardial borders, image quality, reader confidence, and
bserver agreement (24,25). For rapid interpretation at
ight or on weekends, digitally acquired CE images could
e accessed online for RF interpretation (26,27). Patients
ho have normal resting RF could be safely discharged from
he ED and those with abnormal RF could undergo MP
maging.
Because RF and MP studies were assessed independently,
small number of patients with artifacts were classified
ncorrectly as having perfusion defects (those with normal
Table 6. Late Events in Different CE Groups
Event,
n (%)
Normal RF
Normal MP
(n  485)
N
Ab
AMI 7 (1.4)
All-cause mortality 12 (2.5)
Total primary events 19 (3.9)
Unstable angina 13 (2.7)
PCI 11 (2.3)
CABG 6 (1.2)
Total secondary events 30 (6.2)
Abbreviations as in Tables 1 and 2.F at rest). In clinical practice, when RF and MP are
m
rssessed simultaneously, such errors will likely be mini-
ized.
linical implications and conclusions. Contrast echocar-
iography (including RF and MP data) may be useful in
atients presenting to the ED with suspected cardiac CP
ut no ST-segment elevation on the ECG because it
rovides incremental diagnostic and prognostic value over
linical variables. Furthermore, in patients with a low or
ntermediate mTIMI score (4), it effectively identifies
hose who will develop events later.
Current guidelines recommend observation for 4 to 8 h
ollowed by stress testing in patients with negative serum
ardiac markers (28). Because the likelihood of significant
schemia or infarction is exceedingly low in patients with
ormal resting RF, the observation time could be shortened in
atients with this finding, and immediate stress echocardiog-
aphy could be performed. However, the incidence of positive
tress echocardiograms in this population would be low.
Patients with abnormal RF but normal MP were found to
ave an intermediate risk of events. The discordance be-
ween RF and MP could be the result of stunning after the
esolution of acute ischemia, the presence of abundant
ollateral flow, or represent nonischemic cardiomyopathy.
igure 3. Ability of tests performed in a hierarchical order for predicting
ate events. See text for details. Abbreviations as in Figure 1. Open bars 
al RF
al MP
38)
Abnormal RF
Normal MP
(n  164)
Abnormal RF
Abnormal MP
(n  270)
.6) 24 (14.6) 70 (25.9)
) 3 (1.8) 19 (6.9)
.6) 27 (16.4) 89 (33.0)
) 14 (8.5) 41 (15.2)
.6) 5 (3.0) 4 (1.5)
) 0 (0) 6 (2.2)
.6) 19 (12.6) 51 (18.9)orm
norm
(n 
1 (2
0 (0
1 (2
0 (0
1 (2
0 (0
1 (2TIMI; gray bars  mTIMI  RF; black bars  mTIMI  RF MP;
uled bars  TIMI.
F
r
F
i
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Contrast Echocardiography for Chest Pain September 6, 2005:920–7igure 4. Event-free survival in patients with a low-risk modified Thrombolysis In Myocardial Infarction score (0). MP  myocardial perfusion; RF 
egional left ventricular function.igure 5. Event-free survival in patients with an intermediate-risk modified Thrombolysis In Myocardial Infarction score (3 or 4). Abbreviations as
n Figure 4.
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tress echocardiography if serum cardiac markers remained
ormal. The incidence of positive stress echocardiograms in
his population would be relatively high. Alternatively, early
ardiac catheterization could be considered if concurrent
linical variables suggested that the patient belonged to a
igh-risk cohort.
Patients with both abnormal RF and MP are at high risk
or early events and could be triaged even before cardiac
erum marker results become available. Implementation of
his approach in the ED may help streamline the care of
atients presenting with suspected cardiac CP and reduce
ost significantly. Although the cost effectiveness of this
pproach needs to be evaluated, echocardiography (even
ontrast-enhanced) is relatively inexpensive compared with
ther noninvasive imaging modalities. Further studies are
eeded to assess the value of such an approach in an ED.
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PPENDIX
lease see the online version of this article for the accom-
anying videos.
